Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising
Novo Nordisk has filed a lawsuit against rival Eli Lilly alleging deceptive advertising practices in the promotion of GLP-1 weight-loss medications. The Danish pharmaceutical giant is seeking a permanent injunction and corrective advertising from its competitor.